Opendata, web and dolomites

iPSCAtaxia

An induced pluripotent stem cell-based neuronal model of Spinocerebellar ataxia

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 iPSCAtaxia project word cloud

Explore the words cloud of the iPSCAtaxia project. It provides you a very rough idea of what is the project "iPSCAtaxia" about.

developmental    subtypes    ataxic    progression    adapting    disease    electrophysiological    render    suggest    format    pressing    elucidate    model    spinocerebellar    screen    protocol    identification    indicate    validated    ipsc    therapeutics    phenotypes    mouse    pipeline    ataxias    motor    samples    exist    mortem    biochemical    groundbreaking    terminal    abnormalities    pathological    suitable    neurological    differentiation    unravel    molecular    neurodegeneration    successful    genetic    sca    cerebellar    cells    sca14    disorders    vitro    therapeutic    therapies    multiple    first    mechanisms    platform    investigation    sensitive    amenable    body    intervention    progenitor    throughput    pluripotent    compounds    ipscs    group    diverse    41    screening    models    purkinje    degeneration    shared    cerebellum    cell    pathogenesis    opportunity    scas    combination    preliminary    defects    points    clinical    diseases    neurodegenerative    brain    underlying    stem    strategy    neurodevelopmental    causing    post    treatments    transcriptomic   

Project "iPSCAtaxia" data sheet

The following table provides information about the project.

Coordinator
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD 

Organization address
address: WELLINGTON SQUARE UNIVERSITY OFFICES
city: OXFORD
postcode: OX1 2JD
website: www.ox.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://www.dpag.ox.ac.uk/research/becker-group
 Total cost 195˙454 €
 EC max contribution 195˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2016
 Duration (year-month-day) from 2016-07-01   to  2019-01-23

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) coordinator 195˙454.00

Map

 Project objective

The spinocerebellar ataxias (SCAs) are a diverse group of neurological disorders defined by a loss of motor coordination. No effective treatments exist, and there is thus a pressing need for suitable models in which to study disease progression and to screen potential therapies. Induced pluripotent stem cells (iPSCs), which are capable of differentiation into any cell type of the body, offer the opportunity to study neurodegeneration in vitro. The proposed study aims to be the first in Europe to establish an iPSC-derived model of cerebellar disease, focusing on two genetic subtypes of SCA - SCA14 and 41. Increasing evidence points towards common pathological pathways shared across multiple SCA subtypes, which could provide novel therapeutic targets. There is also evidence to suggest that abnormalities in Purkinje cell development may contribute to the pathogenesis of the SCAs. This model will thus be used to elucidate the molecular mechanisms underlying common SCA-causing disease pathways, and to unravel the neurodevelopmental aspects of these diseases, in order to develop early-intervention therapies. Preliminary results indicate successful differentiation of iPSCs into cerebellar progenitor cells, using a protocol I have optimised. Following terminal differentiation, these cells will be investigated for common disease phenotypes and developmental defects, using a combination of transcriptomic, biochemical, and electrophysiological methods. Results will be validated by comparison with post-mortem brain samples and ataxic mouse models. By adapting this differentiation strategy to a format amenable to high-throughput screening, a pipeline will be established for the identification of novel therapeutic compounds. This groundbreaking study will enable the investigation of mechanisms which render the cells of the cerebellum particularly sensitive to degeneration, as well as providing a platform for pre-clinical screening of therapeutics for neurodegenerative conditions.

 Publications

year authors and title journal last update
List of publications.
2018 Maggie M. K. Wong, Stephanie D. Hoekstra, Jane Vowles, Lauren M. Watson, Geraint Fuller, Andrea H. Németh, Sally A. Cowley, Olaf Ansorge, Kevin Talbot, Esther B. E. Becker
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
published pages: , ISSN: 2051-5960, DOI: 10.1186/s40478-018-0600-7
Acta Neuropathologica Communications 6/1 2019-09-27
2018 Lauren M. Watson, Maggie M. K. Wong, Jane Vowles, Sally A. Cowley, Esther B. E. Becker
A Simplified Method for Generating Purkinje Cells from Human-Induced Pluripotent Stem Cells
published pages: 419-427, ISSN: 1473-4222, DOI: 10.1007/s12311-017-0913-2
The Cerebellum 17/4 2019-09-27
2017 Lauren M. Watson, Elizabeth Bamber, Ricardo Parolin Schnekenberg, Jonathan Williams, Conceição Bettencourt, Jennifer Lickiss, Sandeep Jayawant, Katherine Fawcett, Samuel Clokie, Yvonne Wallis, Penny Clouston, David Sims, Henry Houlden, Esther B.E. Becker, Andrea H. Németh
Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44
published pages: 451-458, ISSN: 0002-9297, DOI: 10.1016/j.ajhg.2017.08.005
The American Journal of Human Genetics 101/3 2019-09-27
2017 Esther Becker
Recent advances in modelling of cerebellar ataxia using induced pluripotent stem cells
published pages: 11-15, ISSN: 2572-942X, DOI: 10.29245/2572.942X/2017/7.1134
Journal of Neurology and Neuromedicine 2/7 2019-09-27

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IPSCATAXIA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IPSCATAXIA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

PNAIC (2018)

Positive and Negative Asymmetry in Intergroup Contact: Its Impact on Linguistic Forms of Communication and Physiological Responses

Read More  

NaWaTL (2020)

Narrative, Writing, and the Teotihuacan Language: Exploring Language History Through Phylogenetics, Epigraphy and Iconography

Read More  

MS4Drug (2019)

An Innovative Mass Spectrometry-Based Workflow for Drug Discovery

Read More